Meet MILTON, AZ's AI that can predict 1,000+ diseases
A machine-learning tool developed by AstraZeneca and trained on UK Biobank health record data could predict over 1,000 diseases, before diagnosis, according to a paper in Nature Genetics.
Continue Reading
Study backs role of Novo Nordisk obesity drug in children
A clinical trial has backed the safety and efficacy of one of Novo Nordisk's weight-loss medicines in children as young as six, showing a significant drop in body mass index (BMI). The study used the company's older GLP-1 agonist therapy Saxenda
Continue Reading
UK doctors sceptical of AI's role in treatment
Almost half of UK doctors would not use generative artificial intelligence (GenAI) to treat patients, although there is greater willingness to use it for diagnostic purposes. A survey of 745 doctors carried out by Medscape UK reveals that 47% would not
Continue ReadingPopular News
Roivant's new 'vant' emerges to advance Bayer lung drug
Roivant's latest biotech company launch – Pulmovant – has made its debut with a plan to develop a respiratory drug licensed from Bayer in a deal worth up to $294 million. Pulmovant is tasked with taking forward mosliciguat, an inhaled soluble
Viridian takes aim at Amgen's Tepezza with veligrotug data
Thyroid eye disease (TED) therapy Tepezza – the biggest asset in Amgen's $26 billion takeover of Horizon last year – could soon face competition from a drug in the same class from Viridian Therapeutics. Viridian said that the results of the